Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma
Chihiro Yamamoto, Daisuke Minakata, Daizo Yokoyama, Shuka Furuki, Atsuto Noguchi, Shunsuke Koyama, Takashi Oyama, Rui Murahashi, Hirotomo Nakashima, Takashi Ikeda, Shin‐ichiro Kawaguchi, Kazuki Hyodo, Yumiko Toda, Shoko Ito, Takashi Nagayama, Kento Umino, Kaoru Morita, Masahiro Ashizawa, Masuzu Ueda, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Shin‐ichiro Fujiwara, Yoshinobu Kanda
Topics & Concepts
MedicineChimeric antigen receptorMultiple myelomaOncologyInternal medicineRefractory (planetary science)ChemotherapyImmunotherapyCancerPhysicsAstrobiologyCAR-T cell therapy researchMultiple Myeloma Research and TreatmentsBiosimilars and Bioanalytical Methods